A double-blind, placebo-controlled, randomized trial of XP-828L (800 mg) on the quality of life and clinical symptoms of patients with mild-to-moderate psoriasis.
Altern Med Rev. 2008 Jun;13(2):145-52.
Altern Med Rev. 2008.
PMID: 18590350
Clinical Trial.